News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Palatin Technologies (PTN) to Report Fiscal Year 2013 Second Quarter Results; Teleconference and Webcast to be Held on February 14, 2013



2/8/2013 7:25:18 AM

CRANBURY, N.J., Feb. 8, 2013 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE-MKT: PTN) will announce its second quarter, fiscal year 2013 financial results on Thursday, February 14, 2013 before the open of the U.S. financial markets.

Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on February 14, 2013, which will include discussion of the results of operations in greater detail and an update on corporate developments.

Schedule for the Financial Results Press Release, Conference Call / Webcast

- 2Q Fiscal Year 2013 Financial Results Press Release

2/14/2013 at 7:30 a.m. ET



- 2Q Fiscal Year 2013 Conference Call-Live

2/14/2013 at 11:00 a.m. ET

Domestic Dial-In Number

1-888-539-3678

International Dial-In Number

1-719-325-2329

Passcode

4795478



- 2Q Fiscal Year 2013 Conference Call-Replay

2/14/2013-2/21/2013

Domestic Dial-In Number

1-888-203-1112

International Dial-In Number

1-719-457-0820

Passcode

4795478



Webcast Live and Replay Access

http://www.palatin.com

The webcast and replay can be accessed by logging on to the "Investor/Media Center-Webcasts" section of Palatin's website at http://www.palatin.com

About Palatin Technologies, Inc.
Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential.

SOURCE Palatin Technologies, Inc.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES